We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Lonza to Invest in Portsmouth, NH (USA) Site, Including Mid-Scale Biologics

News   May 05, 2018

 
Lonza to Invest in Portsmouth, NH (USA) Site, Including Mid-Scale Biologics
 
 
 

RELATED ARTICLES

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

Possible Protection from Zika Symptoms Thanks to Dengue Immunity

News

Children with a history of prior dengue virus infection had a significantly lower risk of being symptomatic when infected by Zika virus.

READ MORE

Pre-symptomatic Skin Test for Prion Disease May Replace Brain Biopsy

News

Preclinical detection of prions has proven difficult, but new research suggests skin samples hold early signs of prion disease that precede neurologic symptoms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE